Marcie A. Goldstein
Lawyers
Filters
Constellation Pharmaceuticals Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $224.3 million offering of common stock of Constellation…
IVERIC bio, Inc. Common Stock and Pre-Funded Warrants Offering
Davis Polk advised the sole book-running manager and representative of the several underwriters in connection with a $45 million SEC-registered common stock and pre-funded warrants offering…
Millendo Therapeutics, Inc. $25 Million Offering of Common Shares
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $25 million public offering of 4,166,667 common shares of…
Davis Polk Advises Gong.io on Its $65 Million Funding Round
Davis Polk advised Gong.io as U.S. law counsel in connection with its $65 million funding C round led by Sequoia Capital.
Launched in 2015 and headquartered in San Francisco, Gong…
Century Communities, Inc. $100 Million SEC-Registered At-The-Market Offering
Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by Century Communities, Inc. of its shares of common stock for up to an aggregate amount of …
SiTime Corporation Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $64.3 million initial public offering by SiTime Corporation. SiTime’s common stock…
Agios Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the SEC-registered offering of 9,487,500 shares of common stock of…
ECMOHO Limited Initial Public Offering and Nasdaq Listing
Davis Polk advised the underwriters on the SEC-registered initial public offering by ECMOHO Limited of 4,375,000 American Depositary Shares for gross proceeds of $43.8 million. Each ADS…
Silvergate Capital Corporation $40 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with the $40 million initial public offering of 3,333,333 shares of Class A common stock of Silvergate…
RAPT Therapeutics, Inc. Initial Public Offering
Davis Polk advised the underwriters in connection with a $38.4 million initial public offering of common stock of RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on…